Dr Reddy's acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products India
Following the trademark rights acquisition, Dr Reddy’s will manufacture the Active Pharmaceutical Ingredient (API) and finished drug at its state-of-the-art facilities
Industrial talks | 17/01/2023 | By Sudeep Soparkar
Lotte purchases Bristol Myers Squibb's pharma plant in East Syracuse, New York
The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio
<br />
Industrial talks | 06/01/2023 | By Sudeep Soparkar
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA
Continued pricing pressures in the US and European markets and cost inflation likely to result in 50-100 bps contraction in operating profit margin for ICRA’s sample set in FY2023
<br />
Industrial talks | 05/01/2023 | By Sudeep Soparkar
Granules forges partnership with Greenko for Kakinada plant
The project is estimated to cost Rs 2000 crore and the investment will be spread across five years
Industrial talks | 04/01/2023 | By Sudeep Soparkar
Aurobindo Pharma JV gets SEC recommendation for pneumococcal 15 valent vaccine
PCV15 vaccine was developed by Tergene Biotech and manufactured at AuroVaccines
Industrial talks | 29/12/2022 | By Sudeep Soparkar
Ashraf Allam joins Cadila Pharma as Global COO
Allam has a Bachelor’s degree in Clinical Pharmaceuticals from Egypt and Post-Graduate Management Programmes from leading firms in the US and Europe
<br />
Industrial talks | 20/12/2022 | By Sudeep Soparkar
China-based Fosun Pharma taps big buyout for Hyd-based Gland Pharma
Gland specialises in injectable drugs such as antibiotics, oncology and cardiology treatments and has a presence in about 60 countries
Industrial talks | 13/12/2022 | By Sudeep Soparkar
Polyplus acquires Xpress Biologics to expand plasmid DNA
The acquisition will strategically expand the Polyplus plasmid DNA engineering technology and services portfolio
Industrial talks | 08/12/2022 | By Sudeep Soparkar
Cadila Pharma signs Investment Intention Form with Odisha Govt
The proposed green field pharmaceutical formulations manufacturing unit at Malipada, Bhubaneswar with an initial investment of Rs 100 crores is envisaged to be one of the biggest pharmaceutical manufacturing units in the region
<br />
Industrial talks | 07/12/2022 | By Sudeep Soparkar
Biocon Biologics appoints Shreehas Tambe as MD and CEO
Tambe has shaped and grown the company's biosimilars business
Industrial talks | 06/12/2022 | By Sudeep Soparkar
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy